We recently showed in a novel tamoxifen-inducible CM-specific Lmna deletion model that fulminant cardiomyopathy and pathological fibrosis develops within 4 weeks post cessation of tamoxifen administration [14]. This evidence concerns the gene LMNA and cardiomyopathy.